Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies. (manokatra rohy)

Antun AG, Gleason S, Arellano M, Langston AA, McLemore ML, Gaddh M, el Rassi F, Bernal-Mizrachi L, Galipeau J, Heffner LT Jr, Winton EF, Khoury HJ.

Loharanon-kevitra‎: Cancer 2013;119(21):3784-7.

Rakitra‎: PubMed 23921838

DOI‎: 10.1002/cncr.28253

https://www.ncbi.nlm.nih.gov/pubmed/23921838 (manokatra rohy)

Tranexamic acid for control of haemorrhage in acute promyelocytic leukaemia. (manokatra rohy)

Avvisati G, ten Cate JW, Büller HR, Mandelli F.

Loharanon-kevitra‎: Lancet 1989;334(8655):122-4.

Rakitra‎: PubMed 2567893

https://www.ncbi.nlm.nih.gov/pubmed/2567893 (manokatra rohy)

Tranexamic acid therapy in acute myeloid leukemia: possible reduction of platelet transfusions. (manokatra rohy)

Ben-Bassat I, Douer D, Ramot B.

Loharanon-kevitra‎: Eur J Haematol 1990;45(2):86-9.

Rakitra‎: PubMed 2209824

https://www.ncbi.nlm.nih.gov/pubmed/2209824 (manokatra rohy)

Fibrinolytic inhibitors for cancer-associated bleeding problems. (manokatra rohy)

Dean A, Tuffin P.

Loharanon-kevitra‎: J Pain Symptom Manage 1997;13(1):20-4.

Rakitra‎: PubMed 9029858

https://www.ncbi.nlm.nih.gov/pubmed/9029858 (manokatra rohy)

Autologous stem-cell transplantation without hematopoietic support for the treatment of hematologic malignancies in Jehovah's Witnesses. (manokatra rohy)

Ford PA, Grant SJ, Mick R, Keck G.

Loharanon-kevitra‎: J Clin Oncol 2015;33(15):1674-9.

Rakitra‎: PubMed 25870085

DOI‎: 10.1200/JCO.2014.57.9912

https://www.ncbi.nlm.nih.gov/pubmed/25870085 (manokatra rohy)

Anti-fibrinolytic therapy with aminocaproic acid for the control of bleeding in thrombocytopenic patients. (manokatra rohy)

Garewal HS, Durie BG.

Loharanon-kevitra‎: Scand J Haematol 1985;35(5):497-500.

Rakitra‎: PubMed 4089529

https://www.ncbi.nlm.nih.gov/pubmed/4089529 (manokatra rohy)

Epsilon aminocaproic acid reduces transfusion requirements in patients with thrombocytopenic hemorrhage. (manokatra rohy)

Kalmadi S, Tiu R, Lowe C, Jin T, Kalaycio M.

Loharanon-kevitra‎: Cancer 2006;107(1):136-40.

Rakitra‎: PubMed 16708357

DOI‎: 10.1002/cncr.21958

https://www.ncbi.nlm.nih.gov/pubmed/16708357 (manokatra rohy)

Aminocaproic acid use in hospitalized patients with hematological malignancy: a case series. (manokatra rohy)

Marshall A, Li A, Drucker A, Dzik W.

Loharanon-kevitra‎: Hematol Oncol 2016;34(3):147-53.

Rakitra‎: PubMed 25641349

DOI‎: 10.1002/hon.2189

https://www.ncbi.nlm.nih.gov/pubmed/25641349 (manokatra rohy)

Tranexamic acid to treat life-threatening hemorrhage in prostate cancer associated disseminated intravascular coagulation with excessive fibrinolysis. (manokatra rohy)

Prokopchuk-Gauk O, Brose K.

Loharanon-kevitra‎: Cureus 2015;7(12):e428.

Rakitra‎: PubMed 26848417

DOI‎: 10.7759/cureus.428

https://www.ncbi.nlm.nih.gov/pubmed/26848417 (manokatra rohy)

A controlled trial of tranexamic acid therapy for the reduction of bleeding during treatment of acute myeloid leukemia. (manokatra rohy)

Shpilberg O, Blumenthal R, Sofer O, Katz Y, Chetrit A, Ramot B, Eldor A, Ben-Bassat I.

Loharanon-kevitra‎: Leuk Lymphoma 1995;19(1-2):141-4.

Rakitra‎: PubMed 8574160

DOI‎: 10.3109/10428199509059668

https://www.ncbi.nlm.nih.gov/pubmed/8574160 (manokatra rohy)

Acute promyelocytic leukaemia and acquired alpha-2-plasmin inhibitor deficiency: a retrospective look at the use of epsilon-aminocaproic acid (Amicar) in 30 patients. (manokatra rohy)

Wassenaar T, Black J, Kahl B, Schwartz B, Longo W, Mosher D, Williams E.

Loharanon-kevitra‎: Hematol Oncol 2008;26(4):241-6.

Rakitra‎: PubMed 18613223

DOI‎: 10.1002/hon.867

https://www.ncbi.nlm.nih.gov/pubmed/18613223 (manokatra rohy)

Use of Novoseven for arsenic trioxide-induced bleeding in PML. (manokatra rohy)

Alimoghaddam K, Ghavamzadeh A, Jahani M.

Loharanon-kevitra‎: Am J Hematol 2006;81(9):720.

Rakitra‎: PubMed 16804937

DOI‎: 10.1002/ajh.20713

https://www.ncbi.nlm.nih.gov/pubmed/16804937 (manokatra rohy)

Control of bleeding caused by thrombocytopenia associated with hematologic malignancy: an audit of the clinical use of recombinant activated Factor VII. (manokatra rohy)

Brenner B, Hoffman R, Balashov D, Shutluko E, Čulić SD, Nizamoutdinova E.

Loharanon-kevitra‎: Clin Appl Thromb Hemost 2005;11(4):401-10.

Rakitra‎: PubMed 16244765

https://www.ncbi.nlm.nih.gov/pubmed/16244765 (manokatra rohy)

The off-label use of recombinant FVIIa in the treatment of a patient with T-cell non-Hodgkin lymphoma who developed intra-abdominal and intra-pleural hemorrhages followed by high-dose methotreaxate therapy. (manokatra rohy)

Erduran E, Bahadir A, Mutlu M.

Loharanon-kevitra‎: Eur J Clin Med Oncol 2011;3(5):1-4.

Rakitra‎: EMBASE 2012295551

https://www.worldcat.org/title/european-journal-of-clinical-medical-oncology/oclc/645421559&referer=brief_results (manokatra rohy)

The potential role of recombinant activated FVII in the management of critical hemato-oncological bleeding: a systematic review. (manokatra rohy)

Franchini M, Veneri D, Lippi G.

Loharanon-kevitra‎: Bone Marrow Transplant 2007;39(12):729-35.

Rakitra‎: PubMed 17417659

DOI‎: 10.1038/sj.bmt.1705670

https://www.ncbi.nlm.nih.gov/pubmed/17417659 (manokatra rohy)

Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage. (manokatra rohy)

Gerotziafas GT, Zervas C, Gavrielidis G, Tokmaktsis A, Hatjiharissi E, Papaioannou M, Lazaridou A, Constantinou N, Samama MM, Christakis J.

Loharanon-kevitra‎: Am J Hematol 2002;69(3):219-22.

Rakitra‎: PubMed 11891811

https://www.ncbi.nlm.nih.gov/pubmed/11891811 (manokatra rohy)

Use of recombinant activated factor VII in a Jehovah's Witness patient. (manokatra rohy)

Hsieh A, Cheong I.

Loharanon-kevitra‎: Am J Emerg Med 2007;25(9):1085.e1-2.

Rakitra‎: PubMed 18022514

DOI‎: 10.1016/j.ajem.2007.03.007

https://www.ncbi.nlm.nih.gov/pubmed/18022514 (manokatra rohy)

Clinical experience with recombinant factor VIIa in patients with thrombocytopenia. (manokatra rohy)

Kristensen J, Killander A, Hippe E, Helleberg C, Ellegard J, Holm M, Kutti J, Mellqvist UH, Johansson JE, Glazer S, Hedner U.

Loharanon-kevitra‎: Haemostasis 1996;26 Suppl 1:159-64.

Rakitra‎: PubMed 8904193

https://www.ncbi.nlm.nih.gov/pubmed/8904193 (manokatra rohy)

Successful treatment of severe gastrointestinal bleeding after chemotherapy in acute myeloblastic leukemia with recombinant activated factor VII: report on one case and review of other uses in acute leukemias. (manokatra rohy)

Pamuk GE, Taşçi M, Oztürk E, Demir M.

Loharanon-kevitra‎: Med Oncol 2010;27(1):16-9.

Rakitra‎: PubMed 19137431

DOI‎: 10.1007/s12032-008-9163-y

https://www.ncbi.nlm.nih.gov/pubmed/19137431 (manokatra rohy)

Recombinant factor VIIa for bleeding in refractory thrombocytopenia. (manokatra rohy)

Vidarsson B, Önundarson PT.

Loharanon-kevitra‎: Thromb Haemost 2000;83(4):634-5.

Rakitra‎: PubMed 10780334

https://www.ncbi.nlm.nih.gov/pubmed/10780334 (manokatra rohy)

Effective treatment of life-threatening bleeding with recombinant activated factor VII in a patient with acute promyelocytic leukaemia. (manokatra rohy)

Zver S, Andoljšek D, Černelč P.

Loharanon-kevitra‎: Eur J Haematol 2004;72(6):455-6.

Rakitra‎: PubMed 15128428

DOI‎: 10.1111/j.1600-0609.2004.00237.x

https://www.ncbi.nlm.nih.gov/pubmed/15128428 (manokatra rohy)

Management of bleeding complications of hematologic malignancies. (manokatra rohy)

Green D.

Loharanon-kevitra‎: Semin Thromb Hemost 2007;33(4):427-34.

Rakitra‎: PubMed 17525900

DOI‎: 10.1055/s-2007-976178

https://www.ncbi.nlm.nih.gov/pubmed/17525900 (manokatra rohy)

Vitamin K deficiency in cancer patients referred to a hospital palliative care team with bleeding and the impact of vitamin K replacement on laboratory indicators of vitamin K status. (manokatra rohy)

Harrington DJ, Booth L, Dando N, Cottingham L, Beynon T.

Loharanon-kevitra‎: Int J Lab Hematol 2013;35(4):457-9.

Rakitra‎: PubMed 23216984

DOI‎: 10.1111/ijlh.12035

https://www.ncbi.nlm.nih.gov/pubmed/23216984 (manokatra rohy)

Management of bleeding in patients with advanced cancer. (manokatra rohy)

Pereira J, Phan T.

Loharanon-kevitra‎: Oncologist 2004;9(5):561-70.

Rakitra‎: PubMed 15477642

DOI‎: 10.1634/theoncologist.9-5-561

https://www.ncbi.nlm.nih.gov/pubmed/15477642 (manokatra rohy)

Pilot study on the safety and efficacy of desmopressin for the treatment or prevention of bleeding in patients with hematologic malignancies. (manokatra rohy)

Castaman G, Bona ED, Schiavotto C, Trentin L, D'Emilio A, Rodeghiero F.

Loharanon-kevitra‎: Haematologica 1997;82(5):584-7.

Rakitra‎: PubMed 9407726

https://www.ncbi.nlm.nih.gov/pubmed/9407726 (manokatra rohy)

Desmopressin and other synthetic vasopressin analogues in cancer treatment. (manokatra rohy)

Gomez DE, Ripoll GV, Girón S, Alonso DF.

Loharanon-kevitra‎: Bull Cancer 2006;93(2):E7-12.

Rakitra‎: PubMed 16517412

https://www.ncbi.nlm.nih.gov/pubmed/16517412 (manokatra rohy)